Abstract |
Our recent study found that a new topical 5-aminolevulinic acid-mediated photodynamic therapy (ALA- PDT) protocol composed of multiple 3-min fractionated irradiations with a light emitting diode (LED) red light at 635 +/- 5 nm for a total of 1000 s (fluence rate: 100 mW/cm(2); light exposure dose: 100 J/cm(2)) after topical application of 20% ALA for 1.5 or 2 h can be used successfully for the treatment of oral verrucous hyperplasia. In this case report, we tested the efficacy of this new treatment protocol of ALA- PDT for an extraoral verrucous carcinoma (VC) lesion at the right mouth angle and an intraoral VC lesion at the right buccal mucosa of a 56-year-old male areca quid chewer and smoker. The extraoral tumor was cleared after six treatments of topical ALA- PDT and the intraoral tumor showed complete regression after 22 treatments of topical ALA- PDT. No recurrence of the VC lesion was found after a follow-up period of 6 months. We suggest that PDT using a topical application of 20% ALA followed by multiple 3-min fractionated irradiations with an LED red light is also an effective and successful treatment modality for VC.
|
Authors | Hsin-Ming Chen, Chin-Tin Chen, Hsiang Yang, Ming-I Lee, Mark Yen-Ping Kuo, Ying-Shiung Kuo, Yi-Ping Wang, Tsuimin Tsai, Chun-Pin Chiang |
Journal | Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
(J Oral Pathol Med)
Vol. 34
Issue 4
Pg. 253-6
(Apr 2005)
ISSN: 0904-2512 [Print] Denmark |
PMID | 15752262
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Photosensitizing Agents
- Aminolevulinic Acid
|
Topics |
- Administration, Topical
- Aminolevulinic Acid
(therapeutic use)
- Carcinoma, Verrucous
(drug therapy)
- Dose Fractionation, Radiation
- Follow-Up Studies
- Humans
- Lip Neoplasms
(drug therapy)
- Male
- Middle Aged
- Mouth Neoplasms
(drug therapy)
- Photochemotherapy
(instrumentation, methods)
- Photosensitizing Agents
(therapeutic use)
- Remission Induction
- Treatment Outcome
|